With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...
SEATTLE, WA / / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...
Edited by Margaret Phillips, The University of Texas Southwestern Medical Center, Dallas, TX; received February 21, 2024; accepted November 24, 2024 ...
Drugs most commonly used in this setting are antimalarials and conventional immunosuppressives. Treatment of lupus nephritis Treatment can be divided into an initial phase where treatment is most ...
Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...
Jan. 3, 2025 — Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for ...
Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with those with de novo acral melanoma, according to a study. The American ...